Search

Displaying results 5441 - 5450 of 10000 in total
  1. Drug

    Efimosfermin alfa

    go.drugbank.com/drugs/DB28564
    Investigational

    F2- or F3-stage MASH). … Efimosfermin Alfa is a biologic drug.

  2. Drug

    Narlaprevir

    go.drugbank.com/drugs/DB14760
    Investigational

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  3. Drug

    Cefazedone

    go.drugbank.com/drugs/DB13778
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  4. Drug

    Aspoxicillin

    go.drugbank.com/drugs/DB13816
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  5. Drug

    Cefsulodin

    go.drugbank.com/drugs/DB13499
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  6. Drug

    Buterizine

    go.drugbank.com/drugs/DB20973
    Experimental

    Buterizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Buterizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Buterizine has a monoisotopic molecular weight of 466.31 Da.

  7. Drug

    Lifarizine

    go.drugbank.com/drugs/DB20533
    Experimental

    Lifarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Lifarizine is a antihistaminic/cerebral (or peripheral) vasodilator. … Lifarizine has a monoisotopic molecular weight of 436.26 Da.

  8. Drug

    Becatecarin

    go.drugbank.com/drugs/DB06362
    Investigational

    Becatecarin is a derivative of [rebeccamycin].

  9. Drug

    CX501

    go.drugbank.com/drugs/DB05174
    Investigational

    Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of

  10. Drug

    R-851

    go.drugbank.com/drugs/DB05747
    Experimental

    R-851 is part of the family of immune response modifier (IRM) and it acts in a novel way to stimulate the human body's immnune system to attack virus-infected cells and tumor cells. … It is expected to be topical treatment for cervical displasia and cervical high-risk human papillomavirus (HPV), the sexually transmitted virus that causes most cases of cervical cancer.